July 5, 2017 | EphMRA, Patient-centricity, Richard Head, event, rare diseases
We were delighted to present, exhibit and sponsor this year’s EphMRA Annual Conference in Amsterdam, Netherlands.
Director and EphMRA board member, Richard Head, Director, Jennifer Redfearn and Associate Director, An-hwa Lee represented us at the conference. On the Tuesday An-Hwa, who is a member of the EphMRA Learning and Development Committee, convened one of three of the pre-conference training workshops entitled ‘Skills Workshop: Qualitative’ which covered ethnography and projective techniques as qualitative methodologies.
Find out more https://www.researchpartnership.com/news/2017/06/ephmra-2017-round-up/
This content was provided by Inizio
Latest Content from Inizio
Pegasus scoops the much-coveted “Consultancy of the Year” prize at the PR Week Awards 2014
In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in…
As a non-Russian, trying to understand the complexities of the multiple overlapping levels of Russia’s healthcare system can be baffling at times. Information is often inaccessible or data simply doesn’t…
Brighton-based independent healthcare specialist continues to showcase its digital expertise with shortlist nomination
In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.
In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with…
Pegasus, the UK’s leading independent health communications consultancy, picked up the much coveted ‘Consultancy of the Year’ award at last week’s Communiqué Awards 2014, fighting off stiff competition from the…
If you can only research one ASEAN market, which one do you choose?Our Free Thinking paper investigates the opportunities for pharma in ASEAN and outlines the factors you need to…
Our Free Thinking white paper looks at the opportunities for biosimilars and the threats to innovator biologics.
Marc Yates, Director of Emerging Markets at pharma market research specialist Research Partnership, shares insights from his experience of working in BRIC and beyond.
